UAS
DRONE CORP.
CONDENSED
CONSOLIDATED BALANCE SHEETS
(USD
in thousands, except share and per share data)
| |
June 30, | | |
December 31, | |
| |
2022 | | |
2021 | |
Assets | |
(Unaudited) | | |
| |
Current Assets | |
| | |
| |
Cash and cash equivalents | |
| 3,154 | | |
| 3,560 | |
Other current assets | |
| 52 | | |
| 40 | |
Total Current assets | |
| 3,206 | | |
| 3,600 | |
| |
| | | |
| | |
Lease deposit | |
| 15 | | |
| - | |
| |
| | | |
| | |
Property and
equipment, net | |
| 23 | | |
| 9 | |
Total assets | |
| 3,244 | | |
| 3,609 | |
| |
| | | |
| | |
Liabilities and Shareholders’ Equity | |
| | | |
| | |
Current Liabilities | |
| | | |
| | |
Accounts payable | |
| 77 | | |
| 75 | |
Other accounts liabilities | |
| 98 | | |
| 136 | |
Total current
liabilities | |
| 175 | | |
| 211 | |
| |
| | | |
| | |
Stockholder loans | |
| 301 | | |
| 297 | |
Total liabilities | |
| 476 | | |
| 508 | |
| |
| | | |
| | |
Stockholders’ Equity | |
| | | |
| | |
Common stock of US$ 0.0001 par value each (“Common Stock”): 100,000,000 shares authorized as of June 30, 2022 and December 31, 2021; issued and outstanding 54,118,813 and 54,018,813 shares as of June 30, 2022 and December 31, 2021, respectively. | |
| 5 | | |
| 5 | |
Additional paid-in capital | |
| 9,438 | | |
| 9,115 | |
Accumulated deficit | |
| (6,675 | ) | |
| (6,019 | ) |
Total stockholders’
equity | |
| 2,768 | | |
| 3,101 | |
Total liabilities and
stockholders’ equity | |
| 3,244 | | |
| 3,609 | |
The
accompanying notes are an integral part of the condensed consolidated financial statements.
UAS
DRONE CORP.
CONDENSED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(USD
in thousands, except share and per share data)
| |
Six months ended | | |
Three months ended | |
| |
June 30 | | |
June 30 | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| |
(Unaudited) | | |
(Unaudited) | |
| |
| | |
| | |
| | |
| |
Revenues | |
| - | | |
| 500 | | |
| - | | |
| - | |
Cost of revenues | |
| - | | |
| - | | |
| - | | |
| - | |
Gross profit | |
| - | | |
| 500 | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
Research and development expenses | |
| (9 | ) | |
| - | | |
| (3 | ) | |
| - | |
General and administrative expenses | |
| (658 | ) | |
| (433 | ) | |
| (327 | ) | |
| (271 | ) |
Other income | |
| - | | |
| 132 | | |
| - | | |
| - | |
Operating income (loss) | |
| (667 | ) | |
| 199 | | |
| (330 | ) | |
| (271 | ) |
Financing income (expense), net | |
| 11 | | |
| (366 | ) | |
| 43 | | |
| (147 | ) |
Comprehensive loss | |
| (656 | ) | |
| (167 | ) | |
| (287 | ) | |
| (418 | ) |
| |
| | | |
| | | |
| | | |
| | |
Loss per share (basic and diluted) | |
| (0.01 | ) | |
| (0.00 | ) | |
| (0.01 | ) | |
| (0.00 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average number of shares of common stock outstanding | |
| 54,076,824 | | |
| 44,325,572 | | |
| 54,118,813 | | |
| 48,091,085 | |
The
accompanying notes are an integral part of the condensed consolidated financial statements.
UAS
DRONE CORP.
CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)
(USD
in thousands, except share and per share data)
| |
Number of
Shares | | |
| | |
Additional
paid-in
capital | | |
Accumulated
deficit | | |
Total
stockholders’
deficit | |
| |
| | |
| | |
| | |
| | |
| |
BALANCE AT DECEMBER 31, 2021 | |
| 54,018,813 | | |
| 5 | | |
| 9,115 | | |
| (6,019 | ) | |
| 3,101 | |
Share based compensation for services | |
| 100,000 | | |
| * | | |
| 180 | | |
| - | | |
| 180 | |
Comprehensive loss for three month
ended March 31, 2022 | |
| - | | |
| - | | |
| - | | |
| (369 | ) | |
| (369 | ) |
BALANCE AT MARCH 31, 2022 (Unaudited) | |
| 54,118,813 | | |
| 5 | | |
| 9,295 | | |
| (6,388 | ) | |
| 2,912 | |
Share based compensation for services | |
| - | | |
| - | | |
| 143 | | |
| - | | |
| 143 | |
Comprehensive loss for three months
ended June 30, 2022 | |
| - | | |
| - | | |
| - | | |
| (287 | ) | |
| (287 | ) |
BALANCE AT JUNE 30, 2022 (Unaudited) | |
| 54,118,813 | | |
| 5 | | |
| 9,438 | | |
| (6,675 | ) | |
| 2,768 | |
| |
Number of Shares | | |
| | |
Additional paid-in capital | | |
Accumulated deficit | | |
Total stockholders’
deficit | |
| |
| | |
| | |
| | |
| | |
| |
BALANCE AT DECEMBER 31, 2020 | |
| 40,075,151 | | |
| 4 | | |
| 3,278 | | |
| (5,131 | ) | |
| (1,849 | ) |
Issuance of shares in exchange for convertible loans | |
| 1,093,884 | | |
| * | | |
| 345 | | |
| - | | |
| 345 | |
Share based compensation for services | |
| - | | |
| - | | |
| 38 | | |
| - | | |
| 38 | |
Comprehensive profit for three month
ended March 31, 2021 | |
| - | | |
| - | | |
| - | | |
| 251 | | |
| 251 | |
BALANCE AT MARCH 31, 2021 (Unaudited) | |
| 41,169,035 | | |
| 4 | | |
| 3,661 | | |
| (4,880 | ) | |
| (1,215 | ) |
Issuance of shares in exchange for convertible loans | |
| 349,778 | | |
| * | | |
| 361 | | |
| - | | |
| 361 | |
Issuance of shares for cash (net of issuance expenses) | |
| 12,500,000 | | |
| 1 | | |
| 4,604 | | |
| - | | |
| 4,605 | |
Share based compensation for services | |
| - | | |
| - | | |
| 103 | | |
| - | | |
| 103 | |
Comprehensive loss for three month
ended June 30, 2021 | |
| - | | |
| - | | |
| - | | |
| (418 | ) | |
| (418 | ) |
BALANCE AT JUNE 30, 2021 (Unaudited) | |
| 54,018,813 | | |
| 5 | | |
| 8,729 | | |
| (5,298 | ) | |
| 3,436 | |
| (*) | represents
amount less than $1 thousand. |
UAS
DRONE CORP.
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(USD
in thousands)
| |
Six months ended | |
| |
June 30, | |
| |
2022 | | |
2021 | |
| |
(Unaudited) | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | |
| |
Net loss for the period | |
$ | (656 | ) | |
$ | (167 | ) |
Adjustments required to reconcile net loss for the period to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 1 | | |
| 1 | |
Stock based compensation | |
| 323 | | |
| 141 | |
Interest on loans | |
| 4 | | |
| 5 | |
Expenses with respect to convertible loans and debentures | |
| - | | |
| 326 | |
Increase in other current assets | |
| (12 | ) | |
| (37 | ) |
Increase in accounts payable | |
| 2 | | |
| 16 | |
Decrease in other accounts payable | |
| (38 | ) | |
| (133 | ) |
Net cash provided by (used in) operating activities | |
| (376 | ) | |
| 152 | |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Lease deposit | |
| (15 | ) | |
| | |
Purchase of property and equipment | |
| (15 | ) | |
| - | |
Net cash used in investing activities | |
| (30 | ) | |
| - | |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Proceeds from issuance of shares | |
| - | | |
| 4,649 | |
Repayments of convertible loans | |
| - | | |
| (954 | ) |
Repayments of long term banking institute | |
| - | | |
| (6 | ) |
Net cash provided by financing activities | |
| - | | |
| 3,689 | |
| |
| | | |
| | |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |
| (406 | ) | |
| 3,841 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | |
| 3,560 | | |
| 105 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | |
| 3,154 | | |
| 3,946 | |
Supplemental disclosure of cash flow information: | |
| | | |
| | |
Cash paid during the year for: | |
| | | |
| | |
Interest | |
| - | | |
| 59 | |
Non-cash transactions: | |
| | | |
| | |
Issuance of shares in exchange for convertible loans | |
| - | | |
| 706 | |
Value of option recorded as issuance expenses | |
| - | | |
| 44 | |
The
accompanying notes are an integral part of the condensed consolidated financial statement
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
1 - GENERAL
UAS
Drone Corp. (“the Company” or “USDR”) was incorporated under the laws of the State of Nevada on February 4, 2015.
Prior to the Company’s formation, the operations were functioning under Unlimited Aerial Systems, LLP (“UAS LLP”).
UAS LLP was formed under the laws of the State of Louisiana on August 22, 2014. Effective March 31, 2015, the Company completed a reverse
merger with UAS LLP. The reverse merger was accounted for as a reverse capitalization.
On
March 9, 2020, the Company closed on the Share Exchange Agreement (as defined hereunder), pursuant to which, Duke Robotics, Inc. (“Duke
Inc.”) a corporation incorporated under the laws of the state of Delaware, became a majority-owned subsidiary of the Company. Duke
Inc. has a wholly-owned subsidiary, Duke Airborne Systems Ltd. (“Duke Israel,” and collectively with Duke Inc., “Duke”),
which was formed under the laws of the State of Israel in March 2014 and became the sole subsidiary of Duke after its incorporation.
On April 29, 2020, the Company, Duke
Inc., and UAS Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (“UAS Sub”), executed
an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which UAS Sub merged with and into Duke Inc., with Duke
Inc. surviving as our wholly-owned subsidiary (the “Short-Form Merger”). Upon closing of the Short-Form Merger, each outstanding
share of UAS Sub’s common stock, par value $0.0001 per share, was converted into and became one share of common stock of Duke Inc.,
with Duke Inc. surviving as a wholly-owned subsidiary of the Company.
The
Company (collectively with Duke, the “Group”) is a robotics company dedicated to the development of an advanced robotics
stabilization system that enables remote, real-time, pinpoint accurate firing of small arms and light weapons. The Company’s advanced
robotics system is able to achieve pinpoint accuracy regardless of the movement of the weapons platform or the target.
Effective
October 22, 2020, Company’s common stock in quoted on the OTC Markets Group, Inc.’s OTCQB® tier Venture Market, under
the symbol “USDR”.
The
COVID-19 pandemic has caused states of emergency to be declared in various countries, travel restrictions imposed globally, quarantines
established in certain jurisdictions and various institutions and companies being closed. COVID-19 has also adversely impacted the Group’s
ability to conduct its business effectively due to disruptions to its capabilities, availability and productivity of personnel, while
the Group simultaneously attempts to comply with rapidly changing restrictions, such as travel restrictions, curfews and others. Although
to date these restrictions have not impacted the Group’s operations, the effect on its business, from the spread of COVID-19 and
the actions implemented by the governments of the State of Israel, the United States and elsewhere across the globe, may worsen over
time.
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
1 - GENERAL (continue)
The
spread of COVID-19 may also result in the inability of the Group’s manufacturers to deliver components or finished products on
a timely basis and may also result in the inability of the Group’s suppliers to deliver the parts required by its manufacturers
to complete manufacturing of components or finished products. In addition, governments may divert spending from other budgeted resources
as they seek to reduce and/or stop the spread of COVID-19. Such events may result in a period of business and manufacturing disruption,
and in reduced operations, any of which could materially affect the Group’s business, financial condition and results of operations.
The extent to which COVID-19 impacts the Group’s business will depend on future developments, which are highly uncertain and cannot
be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat
its impact, among others. The Group is actively monitoring the pandemic and it is taking any necessary measures to respond to the situation
in cooperation with the various stakeholders.
Unaudited
Interim Financial Statements
The
accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, prepared in
accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions
to Form 10-Q. In the opinion of management, the financial statements presented herein have not been audited by an independent registered
public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of
management, necessary for a fair statement of the financial condition, results of operations and cash flows for the six-months ended
June 30, 2022. However, these results are not necessarily indicative of results for any other interim period or for the year ended December
31, 2021. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions
for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets,
liabilities, revenues and expenses. Actual amounts could differ from these estimates.
Certain
information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles
have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). These financial statements
should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report published
with the SEC, for the year ended December 31, 2021.
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
Principles
of Consolidation
The
consolidated financial statements are prepared in accordance with GAAP. The consolidated financial statements of the Company include
the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.
Use
of Estimates
The
preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the
United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain
revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results
could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate
to share based compensation.
Derivative
Liabilities and Fair Value of Financial Instruments
Fair
value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments
and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if
the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring
measurement. If the instrument is not considered conventional convertible debt under Accounting Standards Codification (“ASC”)
470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815.
Once
determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in
the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Fair
value of certain of the Company’s financial instruments including cash, accounts receivable, account payable, accrued expenses,
notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair
value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for
measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.
Fair
value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants,
principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect
the risk of non-performance, which includes, among other things, the Company’s credit risk.
Valuation
techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection
and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics
of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820
must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for
inputs and resulting measurement as follows:
Level
1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (continue)
Level
2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in
markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived
principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level
3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the
fair values.
Fair
value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in
their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded
disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period
attributable to the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included
in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.
Recent
Accounting Pronouncements
On October 1, 2021, the Company early
adopted Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and
Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number
of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate
diluted earnings per share for convertible instruments and requires the use of the if-converted method. The new standard was effective
for us beginning January 1, 2022, with early adoption permitted. The adoption of this new standard did not have a material impact on our
consolidated financial statements.
In June 2022, the Financial Accounting
Standards Board issued ASU 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions”, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. This guidance also requires
certain disclosures for equity securities subject to contractual sale restrictions. The new guidance is required to be applied prospectively
with any adjustments from the adoption of the amendments recognized in earnings and disclosed on the date of adoption. This guidance is
effective for the Company for the year ending March 31, 2025 and interim reporting periods during the year ending March 31, 2025. Early
adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on the financial position,
results of operations and cash flows.
Other
new pronouncements issued but not effective as of June 30, 2022 are not expected to have a material impact on the Company’s consolidated
financial statements.
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
3 - SHAREHOLDERS’ EQUITY
On
March 1, 2022, the Company signed an investor relations service agreement with a consultant pursuant to which the Company agreed to pay
the consultant a monthly retainer and in addition, to issue the consultant 300,000 restricted shares of common stock, to be issued in
three tranches. In the event that the agreement is terminated prior to the issuance date, the remaining share obligation shall be void.
On March 17, 2022, the Company issued 100,000 restricted shares of common stock pursuant to the agreement. The Company determined the
value of the shares issued based on the agreement date, at $15 which were recorded as share based compensation expenses in the six months
ended June 30, 2022.
As detailed in Note 8 to the financial
statement as of December 31, 2021, on May 11, 2021, the Company issued certain warrants (the “Warrants”) to purchase up to
12,500,000 shares of the Company’s common stock to eight (8) non-U.S. investors (the “Investors”). The Warrants were
exercisable immediately, have had a term of 18 months and have an exercise price of $0.40 per share. On April 5, 2022, the Company
and the Investors executed an extension agreement (the “Extension”), such that the term of the Warrants was extended so that
they now expire on November 11, 2023. The fair value of the expected additional cash payments as of June 30, 2022 was estimated at $27.
NOTE
4 - STOCK OPTIONS
The
following table presents the Company’s stock option activity the six months ended June 30, 2022:
| |
Number of
Options | | |
Weighted
Average
Exercise
Price | |
Outstanding at December 31,2021 | |
| 2,426,812 | | |
| 0.81 | |
Granted | |
| - | | |
| - | |
Exercised | |
| - | | |
| - | |
Forfeited or expired | |
| - | | |
| - | |
Outstanding on June 30, 2022 | |
| 2,426,812 | | |
| 0.81 | |
Number of options exercisable on June 30, 2022 | |
| 758,680 | | |
| 0.81 | |
The
aggregate intrinsic value of the awards outstanding as of June 30, 2022 is $84. These amounts represent the total intrinsic value,
based on the Company’s stock price of $0.19 as of June 30, 2022, less the weighted exercise price. This represents the potential
amount received by the option holders had all option holders exercised their options as of that date.
The
stock options outstanding as of June 30, 2022, have been separated into exercise prices, as follows:
Exercise price | |
Stock options outstanding | | |
Weighted average
remaining contractual
life – years | | |
Stock options vested | |
| |
As of June 30, 2022 | |
0.0001 | |
| 450,000 | | |
| 3.73 | | |
| 225,000 | |
0.38 | |
| 1,256,822 | | |
| 5.04 | | |
| 0 | |
1.00 | |
| 99,369 | | |
| 5.00 | | |
| 99,369 | |
2.25 | |
| 620,621 | | |
| 5.00 | | |
| 434,311 | |
| |
| 2,426,812 | | |
| 4.69 | | |
| 758,680 | |
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
4 - STOCK OPTIONS (continue)
The
stock options outstanding as of December 31, 2021, have been separated into exercise prices, as follows:
Exercise price | |
Stock options outstanding | | |
Weighted average
remaining contractual
life – years | | |
Stock options vested | |
| |
As of December 31, 2021 | |
0.0001 | |
| 450,000 | | |
| 4.23 | | |
| - | |
0.38 | |
| 1,256,822 | | |
| 5.53 | | |
| - | |
1.00 | |
| 99,369 | | |
| 5.5 | | |
| - | |
2.25 | |
| 620,621 | | |
| 5.5 | | |
| - | |
| |
| 2,426,812 | | |
| 4.78 | | |
| - | |
Compensation
expense recorded by the Company in respect of its stock-based compensation awards for the period ended June 30, 2022 was $308 and are
included in General and Administrative expenses in the Statements of Operations.
NOTE
5 - LEASE AGREEMENT
On April 4, 2022, the Company signed
a lease agreement for an office space in Mevo Carmel Science and Industry Park, Israel for a term of 3 years, with an option to extend
the term of the lease agreement for an additional 2 years. The monthly lease payments under the lease agreement, for the first two years
are approximately $5,200 and for the third year approximately $5,400. The monthly lease payments for the option period will be agreed
between the parties, with a minimum increase of 5% above the third years monthly payments. Per the agreement the Company expects that
the asset will be available for Company’s use 5 months following the signature date, therefore commencement date of the lease agreement
per ASC 842 as not yet been met. Based on the lease agreement terms, the Company made a deposit of $15 as a guarantee for its lease commitments.
NOTE
6 - RELATED PARTIES
A. Transactions
and balances with related parties
| |
| | |
Three months ended June 30 | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| |
| | |
| | |
| | |
| |
General and administrative expenses: | |
| | |
| | |
| | |
| |
Directors and Officers compensation (*) | |
| 282 | | |
| 106 | | |
| 130 | | |
| 52 | |
| |
| | | |
| | | |
| | | |
| | |
(*)Share base compensation | |
| 104 | | |
| 84 | | |
| 41 | | |
| 84 | |
| |
| | | |
| | | |
| | | |
| | |
Financing: | |
| | | |
| | | |
| | | |
| | |
Financing expense | |
| 4 | | |
| 4 | | |
| 2 | | |
| 2 | |
UAS
DRONE CORP.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(USD
in thousands, except share and per share data)
NOTE
6 - RELATED PARTIES (continue)
| B. | Balances
with related parties: |
| |
As of June 30, | | |
As of December 31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Other accounts liabilities | |
| 25 | | |
| 30 | |
Stockholders loans | |
| 279 | | |
| 276 | |
| C. | On March 25, 2021, the Board of Directors appointed Yossi Balucka to serve as its Chief Executive Officer. Mr. Balucka is entitled to
a monthly fee of NIS30,000 (approximately $9,650), reimbursement of expenses and discretionary performance bonus. In conjunction with
the appointment of Mr. Balucka, the Company issued to Mr. Balucka options to purchase 450,000 shares of the Company’s commons stock
at an exercise price of $0.0001 per share, subject to and in accordance with the terms and conditions of an Option Plan. The options shall
vest over a three year period, with 50% of the options to vest on the first anniversary of the grant date, and the balance of 50% of the
options to vest in equal parts on the second and third anniversary of the grant date, respectively, subject to the Mr. Balucka providing
continued services to the Company. The fair value of the options were determined using the Black-Scholes pricing model, assuming a risk
free rate of 0.07%, a volatility factor of 156.12%, dividend yields of 0% and an expected life of 5 years. The total value of share-based
compensation was estimated in an amount of $189. Total share based compensation expenses during the six months ended June 30, 2022 amounted
to $42. |
| |
In addition, in July 2021, the Board of Directors
of the Company approved the issuance options to purchase 490,000 shares of the Company’s Common Stock to its Vice Chairman, directors
and Chief Financial Officer. The options shall vest over a three-year period, with 50% of the options to vest on the first anniversary
of the grant date, and the balance of 50% of the options to vest in equal parts on the second and third anniversary of the grant date.
The fair value of the options were determined using the Black-Scholes pricing
model, assuming a risk free rate of 0.07%, a volatility factor of 156.12%, dividend yields of 0% and an expected life of 6 years. The
total value of share-based compensation was estimated in an amount of $176. Total share based compensation expenses during the six months
ended June 30, 2022 amounted to $62
|
NOTE
7 - SUBSEQUENT EVENTS
On
July 13, 2022 the Company issued 100,000 restricted shares of common stock pursuant to the agreement detailed in note 3 above.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Readers
are advised to review the following discussion and analysis of our financial condition and results of operations together with our consolidated
financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial
statements and related notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2021. Some of the information
contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our
plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. See “Cautionary
Note Regarding Forward-Looking Statements”. You should review the “Risk Factors” section of our Annual Report for the
fiscal year ended December 31, 2021 for a discussion of important factors that could cause actual results to differ materially from the
results described in or implied by the forward-looking statements contained in the following discussion and analysis.
We
are a robotics company dedicated to the development of an advanced robotics system that enables remote, real-time, pinpoint accurate
firing of small arms and light weapons. Our advanced robotics system is able to achieve pinpoint accuracy regardless of the movement
of the weapons platform or the target.
We
were founded in 2014 as Unlimited Aerial Systems, LLP (“UAS LLP”), and until the consummation of the Share Exchange Agreement
(as hereinafter defined), we were a developer and manufacturer of commercial unmanned aerial systems, or drones, with the goal of providing
a superior Quadrotor aerial platform at an affordable price point in the law enforcement and first responder markets.
On
March 9, 2020, we closed on the Share Exchange Agreement (the “Share Exchange Agreement”), pursuant to which Duke Robotics,
Inc., a Delaware corporation (“Duke”) became our majority-owned subsidiary (the “Share Exchange”). Such closing
date is referred to as the “Effective Time.” As a result of the Share Exchange, the Company adopted the business plan of
Duke.
On
April 29, 2020, we, Duke, and UAS Acquisition Corp., a Delaware corporation and our wholly-owned subsidiary (“UAS Sub”),
executed an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which UAS Sub was to merge, upon the satisfaction
of customary closing conditions, with and into Duke, with Duke surviving as our wholly-owned subsidiary (the “Short-Form Merger”).
Pursuant to the Merger Agreement, we intended to acquire the remaining outstanding shares of Duke held by those certain Duke shareholders
that did not participate in the Share Exchange. On June 25, 2020, Duke filed a Certificate of Merger with the State of Delaware, and
consequently, Duke became our wholly-owned subsidiary and the Short-Form Merger was consummated.
Duke
has a wholly-owned subsidiary, Duke Airborne Systems Ltd. (“Duke Israel”), which was formed under the laws of the State of
Israel in March 2014 and became the sole subsidiary of Duke after its incorporation. Our mailing address is 10 HaRimon Street, Mevo Science
and Industrial Park, Israel, 2069203, and our telephone number is 011-972-4-8124101.
Readers
are cautioned that to date, we have generated limited revenues and have not yet begun meaningful commercialization efforts with respect
to our products. We intend in the long-term to derive substantial revenues from the sales of our products as well as future models of
other robots and our unmanned aerial system (“UAS”) platforms for both military and civilian use, but there can be no assurance
that we will be able to do so.
On
January 29, 2021, we, through Duke Israel, and Elbit Systems Land Ltd., an Israeli corporation (“Elbit”), entered into a
collaboration agreement (the “Collaboration Agreement”) for the global marketing and sales, and the production and further
development of our developed advanced robotic system mounted on an UAS, armed with lightweight firearms, which we market under the commercial
name “TIKAD.”
As
of the date of this quarterly report, to date, we have not experienced any material impact on our financial condition and results of
operations due to COVID-19, and we do not expect to experience any material impact on our overall liquidity positions and outlook as
a result of the outbreak. Nevertheless, given that COVID-19 is still an ongoing event in different parts of the world, it is still not
possible at this time to estimate the full impact that the COVID-19 pandemic, the continued spread of COVID-19, and any additional measures
taken by governments, health officials or by us in response to such spread, could have on our business results of operations and financial
condition.
Critical
Accounting Policies
Please
see Note 2 of Part I, Item 1 of this Quarterly Report on Form 10-Q for the summary of significant accounting policies. In addition, reference
is made to Part I, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation of our Annual Report
on Form 10-K for the year ended December 31, 2021 (filed on March 7, 2022) with respect to our Critical Accounting Policies and Estimates.
The main changes to our critical accounting policies and estimates since our Annual Report on Form 10-K for the year ended December 31,
2021, relates to convertible loans Derivative Liabilities and Fair Value of Financial Instruments.
Results
of Operations
Comparison
of the three months ended June 30, 2022 and 2021
Revenues.
We did not generate any revenues during the three months ended June 30, 2022 and June 30, 2021.
Research
and Development. Our research and development expenses for the three months ended June 30, 2022, amounted to $3,000, compared to $0
for the three months ended June 30, 2021. Our research and development expenses, for the three months ended June 30, 2022, consisted
primarily of professional services.
General
and Administrative. Our general and administrative expenses for the three months ended June 30, 2022, which consisted primarily of
professional services, stock-based compensation expenses and legal expenses, amounted to $327,000, compared to $271,000 for the three
months ended June 30, 2021. The increase in general and administrative expenses for the three months ended June 30, 2022 was mainly due
to an increase in stock-based compensation of $51,000.
Financial
Income (expense). For the three months ended June 30, 2022, we had financial income of $43,000 compared to financial expense of $147,000
for the three months ended June 30, 2021. The reason for the decrease in financial expense for the three months ended June 30, 2022,
was mainly due to the decrease in interest expense related to our previously outstanding convertible loans which have been repaid or
converted in full.
Net
Loss. We incurred a net loss of $287,000 for the three months ended June 30, 2022 as compared to $418,000 for the three months ended
June 30, 2021, for the reasons set forth above.
Comparison
of the six months ended June 30, 2022 and 2021
Revenues. We did not
generate any revenues during the six months ended June 30, 2022 . We had revenues of $500,000 for the six months ended June 30, 2021,
which were derived from the Collaboration Agreement.
Research
and Development. Our research and development expenses for the six months ended June 30, 2022, amounted to $9,000, compare to none
for the six months ended June 30, 2021. Our research and development expenses, for the six months ended June 30, 2022, consisted primarily
of professional services.
General
and Administrative. Our general and administrative expenses for the six months ended June 30, 2022, which consisted primarily of
professional services, stock-based compensation expenses and legal expenses, amounted to $658,000, compared to $433,000 for the six months
ended June 30, 2021. The increase in general and administrative expenses for the six months ended June 30, 2022 was mainly due to an
increase in stock-based compensation and professional services.
Other Income. For the six months ended
June 30, 2021 we had other income of $132 resulting from waiver of consulting fees accrued by March 31, 2021.
Financial
Income (expense). For the six months ended June 30, 2022, we had financial income of $11,000 compared to financial expense of $366,000
for the six months ended June 30, 2021. The reason for the decrease in financial expense for the six months ended June 30, 2022, was
mainly due to the decrease in interest expense related to our previously outstanding convertible loans which have been repaid or converted
in full.
Net
Loss. We incurred a net loss of $656,000 for the six months ended June 30, 2022 as compared to a net loss of $167,000 for the six
months ended June 30, 2021, for the reasons set forth above.
Liquidity
and Capital Resources
We had $3,154,000 in cash
on June 30, 2022 versus $3,946,000 in cash at June 30, 2021. The reason for the decrease in our cash balance was due to the operating
expenses describe above. Cash used in operations for the six months ended June 30, 2022 was $376,000 as compared to cash provided by operations
of $152,000 for the six months ended June 30, 2021. The reason for the increase in cash used in operations is mainly related to the increase
in the net loss and the decrease in expenses with respect to convertible loans and debentures, partially offset by an increase in stock-based
compensation.
Net
cash used in investing activities was $30,000 for the six months ended June 30, 2022, as compared to net cash used in financing activities
of $0 for the six months ended June 30, 2021. The increase is related to investments in office improvements and lease deposit.
Net cash used in financing
activities was $0 for the six months ended June 30, 2022, as compared to net cash used in financing activities of $3,689,000 for the six
months ended June 30, 2021. The decrease is a result of proceeds from a private placement transaction we completed in May 2021 and the
full repayment of a convertible loans in 2021.
On
September 2, 2019, we executed a promissory note having a total principal amount of $35,000 bearing interest at a 6% per annum and maturing
on September 2, 2021 (the “Promissory Note”). The Promissory Note was a non-recourse and carried no personal guarantees.
In conjunction with the consummation of the Share Exchange, and as a condition thereof, on March 6, 2020, we entered into several Securities
Exchange Agreements, on the same terms, to exchange the Promissory Note for 9,623,621 shares of our common stock, par value $0.0001 per
share (the “Common Stock”). On May 18, 2021, we issued 54,019 shares of Common Stock of the Company, to several holders pursuant
to the terms of the Security Exchange Agreements pursuant to which, such holders were entitled to an anti-dilution clause in the event
that the Convertible Debentures were converted into shares of our Common Stock.
In
connection with the Share Exchange, immediately prior to the Effective Time, we entered into several convertible loan agreements, on
the same terms, in the aggregate amount of $965,000 (each, a “Convertible Loan Agreement”). The terms of the Convertible
Loan Agreements required repayment of the borrowed amount by the one-year anniversary of the Effective Time, unless, at our discretion,
and subject to its compliance with any and all terms of the material terms of the Convertible Loan Agreements, the term of such loans
is extended for an additional twelve (12) month period. The terms of the Convertible Loan Agreements also provide that we may repay any
portion of the remaining outstanding loan amount, without penalty, provided, however, that the Company provides the specific lender with
three business days’ written notice prior to such repayment, during which time the lender may elect to convert any or all of the
outstanding loan amount into shares of common stock of the Company. The Convertible Loan Agreements bore simple interest at a rate equal
to 15% per annum, payable on the 15th day of each calendar month. On December 9, 2020, we utilized our rights under the Convertible Loan
Agreements and extended the terms of the loans for an additional twelve months. During May 2021, we repaid the full balance of the principal
of the Convertible Loans in the amount of $835,000.
Also,
in connection with the Share Exchange, we entered into securities exchange agreements (each, an “Exchange Agreement”) with
our outstanding debt, Alpha Capital Anstalt (“Alpha”) and GreenBlock Capital LLC (“GBC”) to respectively cancel
existing debentures or debt in the total amount of $658,323 and in exchange issue new debentures in the aggregate amount of $400,000
and issue 698,755 and 65,198 shares of common stock to each of Alpha and GBC, respectively. The New Debentures matured three years from
the Effective Date, bore interest at a rate of 8% per year and were only convertible into shares of the Company’s common stock,
at an original conversion price of $0.3740 (the “Original Conversion Price”); provided, however, that such Original Conversion
Price shall be adjusted downward in the event that the Company, as applicable, sells or grants any options to purchase or sells or grants
any right to reprice, or otherwise dispose or issues any common stock or common stock equivalents entitling any purchaser to acquire
shares of the Company’s common stock at an effective price per share that is lower than the Original Conversion Price (such issuance,
a “Dilutive Event”). In the event of a Dilutive Event at any time from the Effective Time through the six (6) month anniversary
of the Effective Time, any such adjustment shall occur immediately after the completion of such period. Subsequent to March 31,
2021, a portion of the Convertible Debentures, representing an aggregate amount of $110,614 (including interest) was converted into 295,759
shares of Common Stock. During May 2021, we prepaid the full balance of the principal and interest amount of the Convertible Debentures
in the amount of $108,541.
On May 11, 2021, we entered
into Securities Purchase Agreements with eight (8) non-U.S. investors (the “Investors”), pursuant to which we, in a private
placement offering (the “Offering”), agreed to issue and sell to the Investors an aggregate of: (i) 12,500,000 shares of our
Common Stock at a price of $0.40 per share; and (ii) warrants (the “Warrants”) to purchase 12,500,000 of our Common Stock.
The Warrants are exercisable immediately and for a term of 18 months and have an exercise price of $0.40 per share. The aggregate gross
proceeds from the Offering were approximately $5,000,000 and the Offering closed on May 11, 2021. On April 5, 2022, we entered into an
agreement with the Investors pursuant to which we extended the term of the Warrants, which now expire on November 11, 2023. The fair value
of the expected additional cash payments as of June 30, 2022 was estimated at $27.
In
view of our cash balance following the above transactions, we anticipate that our cash balances will be sufficient to permit us to conduct
our operations up to the end of 2023. We may also satisfy its liquidity through the sale of its securities, either in public or
private transactions.
If
we are unable to obtain sufficient amounts of additional capital, we may be required to reduce the scope of our planned development,
which could harm our business, financial condition and operating results. If we obtain additional funds by selling any of our equity
securities or by issuing common stock to pay current or future obligations, the percentage ownership of our stockholders will be reduced,
stockholders may experience additional dilution, or the equity securities may have rights preferences or privileges senior to the Common
Stock. If adequate funds are not available to us when needed on satisfactory terms, we may be required to cease operating or otherwise
modify our business strategy.